Biohit Oyj
Biohit Oyj expands the distribution of Acetium® lozenge to dental care
DGAP-News: Biohit Oyj 2015-06-12 / 08:30 --------------------------------------------------------------------- Biohit Oyj Press Release June 12, 2015 at 9:30 a.m. local time (EEST) Hammasväline Oy begins the distribution of the Acetium lozenges which increases the distribution opportunities in professional dental care. Hammasväline is a part of the North European Lifco Dental Group, which is owned by Swedish Lifco Ab. The Acetium(R) lozenge is intended to protect the mouth by binding acetaldehyde dissolved into saliva during smoking and alcohol consumption. Acetaldehyde is the most important carcinogen in cigarette smoke. Finnish Oriola Oy supplies the Acetium(R) lozenges to Hammasväline Oy. The agreement between Biohit Oyj and Oriola Oy came into force on June 1st, 2015. With the agreement, Oriola has exclusive rights for the distribution of Acetium(R) products in Finland. CEO Semi Korpela, Biohit Oyj: 'The most important risk factors of oral cancer are tobacco and alcohol, and together they increase the risk exponentially. During smoking the carcinogenic acetaldehyde concentration in saliva is approximately 10mg/l. Acetium lozenge for smokers is a method developed by Biohit that removes effectively acetaldehyde from smoker's saliva (see Additional information).' Marketing manager Hannele Nokia, Hammasväline Oy: 'Poor oral hygiene together with smoking increases the amount of acetaldehyde in mouth. With Acetium lozenge it is possible to eliminate the acetaldehyde dissolved into saliva almost completely. Biohit's Acetium lozenges fit well in our selection of oral health promoting products.' Additional information: CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 investor.relations@biohit.fi www.biohithealthcare.com Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit's mission is 'Innovating for Health' - we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com Hammasväline in brief Hammasväline is Finland's leading supplier of dental care products, serving private and municipal dental care professionals by importing and providing dental supplies, equipment and furniture solutions as well as developing and offering services for the oral health care. Hammasväline's aim is to enable dental care professionals to focus on profitable and high-quality patient treatment. The number of our employees in Finland is approximately 80 persons. We belong to North European Lifco Dental Group. News Source: NASDAQ OMX --------------------------------------------------------------------- 2015-06-12 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Biohit Oyj Finland ISIN: FI0009005482 End of News DGAP News-Service --------------------------------------------------------------------- 367741 2015-06-12
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden